Replies to post #158478 on Biotech Values

[mcbio]

I don't even have a position in the company right now, was going to buy some today when the market was supposed to collapse. It didn't happen LOL. I found the drug interesting. That's all!

What odds do you give to the positive ET data carrying over to MF? And what do you see as potential upside for GERN shares if that MF data due by the end of the year is positive? Conversely, thoughts on impact to share price if data is negative? (I'm fairly nervous on the latter scenario as I can't see too much value being assigned to imetelstat if that's how it plays out.)